1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Capsule
        1.2.3 Pills
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Symmetrical Neuropathy
        1.3.3 Focal and Multifocal Neuropathy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2017-2028)
    2.2 Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Region
        2.2.1 Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Region (2017-2022)
        2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2023-2028)
    2.3 Diabetic Neurological Disorder Therapeutic Drug Market Dynamics
        2.3.1 Diabetic Neurological Disorder Therapeutic Drug Industry Trends
        2.3.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers
        2.3.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges
        2.3.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue
        3.1.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue (2017-2022)
        3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2017-2022)
    3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue
    3.4 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio
        3.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2021
    3.5 Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Area Served
    3.6 Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
    3.7 Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Type
    4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2017-2022)
    4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2023-2028)
5 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Application
    5.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Application (2017-2022)
    5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
    6.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
        6.2.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
        6.2.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
        6.2.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
    6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
        6.3.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
        6.3.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
        6.3.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
    6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
        6.4.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
        6.4.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
    7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
        7.2.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
        7.2.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
        7.2.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
    7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
        7.3.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
        7.3.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
        7.3.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
    7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
        7.4.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
        7.4.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
    8.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
        8.2.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
    8.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
        8.3.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
    8.4 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region
        8.4.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
    9.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
        9.2.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
        9.2.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
        9.2.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
    9.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
        9.3.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
        9.3.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
        9.3.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
    9.4 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
        9.4.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
        9.4.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size (2017-2028)
    10.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type
        10.2.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Type (2017-2028)
    10.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application
        10.3.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Application (2017-2028)
    10.4 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country
        10.4.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.1.5 AstraZeneca Recent Developments
    11.2 Johnson & Johnson
        11.2.1 Johnson & Johnson Company Details
        11.2.2 Johnson & Johnson Business Overview
        11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.2.5 Johnson & Johnson Recent Developments
    11.3 Takeda
        11.3.1 Takeda Company Details
        11.3.2 Takeda Business Overview
        11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.3.5 Takeda Recent Developments
    11.4 Mitsubishi Chemical
        11.4.1 Mitsubishi Chemical Company Details
        11.4.2 Mitsubishi Chemical Business Overview
        11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.4.5 Mitsubishi Chemical Recent Developments
    11.5 Avanir Pharmaceuticals
        11.5.1 Avanir Pharmaceuticals Company Details
        11.5.2 Avanir Pharmaceuticals Business Overview
        11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.5.5 Avanir Pharmaceuticals Recent Developments
    11.6 Dong-A Pharmaceutical Co., Ltd.
        11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Details
        11.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview
        11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Developments
    11.7 Immune Pharmaceuticals
        11.7.1 Immune Pharmaceuticals Company Details
        11.7.2 Immune Pharmaceuticals Business Overview
        11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.7.5 Immune Pharmaceuticals Recent Developments
    11.8 MediciNova
        11.8.1 MediciNova Company Details
        11.8.2 MediciNova Business Overview
        11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.8.5 MediciNova Recent Developments
    11.9 Sangamo BioSciences
        11.9.1 Sangamo BioSciences Company Details
        11.9.2 Sangamo BioSciences Business Overview
        11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction
        11.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
        11.9.5 Sangamo BioSciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Capsule
    Table 3. Key Players of Pills
    Table 4. Key Players of Other
    Table 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2017-2022)
    Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2023-2028)
    Table 11. Diabetic Neurological Disorder Therapeutic Drug Market Trends
    Table 12. Diabetic Neurological Disorder Therapeutic Drug Market Drivers
    Table 13. Diabetic Neurological Disorder Therapeutic Drug Market Challenges
    Table 14. Diabetic Neurological Disorder Therapeutic Drug Market Restraints
    Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Players (2017-2022)
    Table 17. Global Top Diabetic Neurological Disorder Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2021)
    Table 18. Ranking of Global Top Diabetic Neurological Disorder Therapeutic Drug Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
    Table 22. Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2017-2022)
    Table 26. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2023-2028)
    Table 28. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Application (2017-2022)
    Table 30. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Share by Application (2023-2028)
    Table 32. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2023-2028) & (US$ Million)
    Table 62. AstraZeneca Company Details
    Table 63. AstraZeneca Business Overview
    Table 64. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product
    Table 65. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 66. AstraZeneca Recent Developments
    Table 67. Johnson & Johnson Company Details
    Table 68. Johnson & Johnson Business Overview
    Table 69. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product
    Table 70. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 71. Johnson & Johnson Recent Developments
    Table 72. Takeda Company Details
    Table 73. Takeda Business Overview
    Table 74. Takeda Diabetic Neurological Disorder Therapeutic Drug Product
    Table 75. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 76. Takeda Recent Developments
    Table 77. Mitsubishi Chemical Company Details
    Table 78. Mitsubishi Chemical Business Overview
    Table 79. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product
    Table 80. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 81. Mitsubishi Chemical Recent Developments
    Table 82. Avanir Pharmaceuticals Company Details
    Table 83. Avanir Pharmaceuticals Business Overview
    Table 84. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
    Table 85. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 86. Avanir Pharmaceuticals Recent Developments
    Table 87. Dong-A Pharmaceutical Co., Ltd. Company Details
    Table 88. Dong-A Pharmaceutical Co., Ltd. Business Overview
    Table 89. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product
    Table 90. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 91. Dong-A Pharmaceutical Co., Ltd. Recent Developments
    Table 92. Immune Pharmaceuticals Company Details
    Table 93. Immune Pharmaceuticals Business Overview
    Table 94. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
    Table 95. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 96. Immune Pharmaceuticals Recent Developments
    Table 97. MediciNova Company Details
    Table 98. MediciNova Business Overview
    Table 99. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product
    Table 100. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 101. MediciNova Recent Developments
    Table 102. Sangamo BioSciences Company Details
    Table 103. Sangamo BioSciences Business Overview
    Table 104. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product
    Table 105. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022) & (US$ Million)
    Table 106. Sangamo BioSciences Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2021 VS 2028
    Figure 2. Capsule Features
    Figure 3. Pills Features
    Figure 4. Other Features
    Figure 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2021 VS 2028
    Figure 6. Symmetrical Neuropathy Case Studies
    Figure 7. Focal and Multifocal Neuropathy Case Studies
    Figure 8. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
    Figure 9. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region: 2021 VS 2028
    Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2021
    Figure 13. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2021
    Figure 15. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
    Figure 17. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
    Figure 18. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
    Figure 19. United States Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
    Figure 25. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Region (2017-2028)
    Figure 35. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
    Figure 45. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Share by Country (2017-2028)
    Figure 51. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 55. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 56. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 57. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 58. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 59. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 60. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 61. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 62. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed